Da. Ross et al., VITAMIN-A SUPPLEMENTATION IN NORTHERN GHANA - EFFECTS ON CLINIC ATTENDANCES, HOSPITAL ADMISSIONS, AND CHILD-MORTALITY, Lancet, 342(8862), 1993, pp. 7-12
Although most studies on the effect of vitamin A supplementation have
reported reductions in childhood mortality, the effects on morbidity a
re less clear. We have carried out two double-blind, randomised, place
bo-controlled trials of vitamin A supplementation in adjacent populati
ons in northern Ghana to assess the impact on childhood morbidity and
mortality. The Survival Study included 21 906 children aged 6-90 month
s in 185 geographical clusters, who were followed for up to 26 months.
The Health Study included 1455 children aged 6-59 months, who were mo
nitored weekly for a year. Children were randomly assigned either 200
000 IU retinol equivalent (100 000 IU under 12 months) or placebo ever
y 4 months; randomisation was by individual in the Health Study and by
cluster in the Survival Study. There were no significant differences
in the Health Study between the vitamin A and placebo groups in the pr
evalence of diarrhoea or acute respiratory infections; of the symptoms
and conditions specifically asked about, only vomiting and anorexia w
ere significantly less frequent in the supplemented children. Vitamin-
A-supplemented children had significantly fewer attendances at clinics
(rate ratio 0.88 [95% CI 0.81-0.95], p=0.001), hospital admissions (0
.62 [0.42-0.93], p=0.02), and deaths (0.81 [0.68-0.98], p=0.03) than c
hildren who received placebo. The extent of the effect on morbidity an
d mortality did not vary significantly with age or sex. However, the m
ortality rate due to acute gastroenteritis was lower in vitamin-A-supp
lemented than in placebo clusters (0.66 [0.47-0.92], p=0.02); mortalit
y rates for all other causes except acute lower respiratory infections
and malaria were also lower in vitamin A clusters, but not significan
tly so. Improving the vitamin A intake of young children in population
s where xerophthalmia exists, even at relatively low prevalence, shoul
d be a high priority for health and agricultural services in Africa an
d elsewhere.